Related references
Note: Only part of the references are listed.A role for O-1602 and G protein-coupled receptor GPR55 in the control of colonic motility in mice
Kun Li et al.
NEUROPHARMACOLOGY (2013)
Endocannabinoid crosstalk between placenta and maternal fat in a baboon model (Papio spp.) of obesity
B. Brocato et al.
PLACENTA (2013)
Randomized pharmacodynamic and pharmacogenetic trial of dronabinol effects on colon transit in irritable bowel syndrome-diarrhea
B. S. Wong et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2012)
Pharmacogenetic Trial of a Cannabinoid Agonist Shows Reduced Fasting Colonic Motility in Patients With Nonconstipated Irritable Bowel Syndrome
Banny S. Wong et al.
GASTROENTEROLOGY (2011)
Blockade of Endocannabinoid Hydrolytic Enzymes Attenuates Precipitated Opioid Withdrawal Symptoms in Mice
Divya Ramesh et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2011)
Chronic monoacylglycerol lipase blockade causes functional antagonism of the endocannabinoid system
Joel E. Schlosburg et al.
NATURE NEUROSCIENCE (2010)
Inhibitors of Endocannabinoid-Metabolizing Enzymes Reduce Precipitated Withdrawal Responses in THC-Dependent Mice
Joel E. Schlosburg et al.
AAPS JOURNAL (2009)
Review article: visceral hypersensitivity in irritable bowel syndrome: molecular mechanisms and therapeutic agents
A. Akbar et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2009)
CB1 Receptors Mediate the Analgesic Effects of Cannabinoids on Colorectal Distension-Induced Visceral Pain in Rodents
Mikael Brusberg et al.
JOURNAL OF NEUROSCIENCE (2009)
The identification of peroxisome proliferator-activated receptor alpha-independent effects of oleoylethanolamide on intestinal transit in mice
N. L. Cluny et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2009)
Dual blockade of FAAH and MAGL identifies behavioral processes regulated by endocannabinoid crosstalk in vivo
Jonathan Z. Long et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
The endocannabinoid system and gut-brain signalling
Martin A. Storr et al.
CURRENT OPINION IN PHARMACOLOGY (2007)
Quantitative method for the profiling of the endocannabinoid metabolome by LC-atmospheric pressure chemical ionization-MS
John Williams et al.
ANALYTICAL CHEMISTRY (2007)
Effects of a cannabinoid receptor agonist on colonic motor and sensory functions in humans: a randomized, placebo-controlled study
Tuba Esfandyari et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2007)
Therapeutic potential of cannabinoid receptor agonists as analgesic agents
A Fox et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2005)
Distribution and function of the cannabinoid-1 receptor in the modulation of ion transport in the guinea pig ileum: relationship to capsaicin-sensitive nerves
WK MacNaughton et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2004)
Simultaneous determination of endocannabinoids (arachidonylethanolamide and 2-arachidonylglycerol) and isoprostane (8-epiprostaglandin F2α) by gas chromatography-mass spectrometry-selected ion monitoring for medical samples
T Obata et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2003)
Differential distribution of functional cannabinoid CB1 receptors in the mouse gastroenteric tract
MA Casu et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2003)
Modulation of anxiety through blockade of anandamide hydrolysis
S Kathuria et al.
NATURE MEDICINE (2003)
Localisation of cannabinoid receptor 1 in rat dorsal root ganglion using in situ hybridisation and immunohistochemistry
D Bridges et al.
NEUROSCIENCE (2003)
Therapeutic potential of cannabinoids in CNS disease
JL Croxford
CNS DRUGS (2003)
Endocannabinoids as physiological regulators of colonic propulsion in mice
L Pinto et al.
GASTROENTEROLOGY (2002)
Localisation of cannabinoid CB1 receptor immunoreactivity in the guinea pig and rat myenteric plexus
AA Coutts et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2002)
The palmitoylethanolamide family: A new class of anti-inflammatory agents?
DM Lambert et al.
CURRENT MEDICINAL CHEMISTRY (2002)
Inhibitory effect of palmitoylethanolamide on gastrointestinal motility in mice
R Capasso et al.
BRITISH JOURNAL OF PHARMACOLOGY (2001)
Cannabinoid CB1-receptor mediated regulation of gastrointestinal motility in mice in a model of intestinal inflammation
AA Izzo et al.
BRITISH JOURNAL OF PHARMACOLOGY (2001)
Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase
BF Cravatt et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
British Society of Gastroenterology guidelines for the management of the irritable bowel syndrome
J Jones et al.
GUT (2000)
Localization of CB1-cannabinoid receptor immunoreactivity in the porcine enteric nervous system
A Kulkarni-Narla et al.
CELL AND TISSUE RESEARCH (2000)
Anandamide amidohydrolase (fatty acid amide hydrolase)
N Ueda et al.
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2000)